1. Home
  2. TNGX vs FRMEP Comparison

TNGX vs FRMEP Comparison

Compare TNGX & FRMEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • FRMEP
  • Stock Information
  • Founded
  • TNGX 2014
  • FRMEP N/A
  • Country
  • TNGX United States
  • FRMEP United States
  • Employees
  • TNGX N/A
  • FRMEP 2162
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • FRMEP Major Banks
  • Sector
  • TNGX Health Care
  • FRMEP Finance
  • Exchange
  • TNGX Nasdaq
  • FRMEP Nasdaq
  • Market Cap
  • TNGX 735.0M
  • FRMEP N/A
  • IPO Year
  • TNGX N/A
  • FRMEP N/A
  • Fundamental
  • Price
  • TNGX $6.64
  • FRMEP $25.56
  • Analyst Decision
  • TNGX Strong Buy
  • FRMEP
  • Analyst Count
  • TNGX 8
  • FRMEP 0
  • Target Price
  • TNGX $15.14
  • FRMEP N/A
  • AVG Volume (30 Days)
  • TNGX 885.7K
  • FRMEP N/A
  • Earning Date
  • TNGX 11-06-2024
  • FRMEP N/A
  • Dividend Yield
  • TNGX N/A
  • FRMEP N/A
  • EPS Growth
  • TNGX N/A
  • FRMEP N/A
  • EPS
  • TNGX N/A
  • FRMEP N/A
  • Revenue
  • TNGX $42,509,000.00
  • FRMEP N/A
  • Revenue This Year
  • TNGX $18.15
  • FRMEP N/A
  • Revenue Next Year
  • TNGX N/A
  • FRMEP N/A
  • P/E Ratio
  • TNGX N/A
  • FRMEP N/A
  • Revenue Growth
  • TNGX 26.16
  • FRMEP N/A
  • 52 Week Low
  • TNGX $6.33
  • FRMEP N/A
  • 52 Week High
  • TNGX $13.01
  • FRMEP N/A
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 37.15
  • FRMEP 58.43
  • Support Level
  • TNGX $6.83
  • FRMEP $25.32
  • Resistance Level
  • TNGX $7.47
  • FRMEP $25.52
  • Average True Range (ATR)
  • TNGX 0.37
  • FRMEP 0.08
  • MACD
  • TNGX 0.11
  • FRMEP 0.00
  • Stochastic Oscillator
  • TNGX 27.31
  • FRMEP 100.00

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About FRMEP First Merchants Corporation Depository Shares

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

Share on Social Networks: